<!DOCTYPE html><html><head><title>Chronic obstructive pulmonary disease (COPD): hospital 30-day, all-cause, risk-standardized mortality rate following COPD hospitalization.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">Chronic obstructive pulmonary disease (COPD): hospital 30-day, all-cause, risk-standardized mortality rate following COPD hospitalization.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 condition-specific measures updates and specifications report: hospital-level 30-day risk-standardized mortality measures. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Mar. 98 p.  [29 references]</td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Outcome
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure estimates a hospital-level 30-day risk-standardized mortality rate (RSMR) for patients discharged from the hospital with either a principal diagnosis of chronic obstructive pulmonary disease (COPD) or a principal diagnosis of respiratory failure and secondary diagnosis of COPD with exacerbation. Mortality is defined as death from any cause within 30 days of the start of the index admission.</p>
<p>The Centers for Medicare &amp; Medicaid Services (CMS) annually reports the measure for individuals who are 65 years and older and are Medicare Fee-for-Service (FFS) beneficiaries hospitalized in non-federal short-term acute care hospitals (including Indian Health Services hospitals) and critical access hospitals.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Measurement of patient outcomes allows for a more comprehensive view of quality of care, encompassing more than that captured by individual process-of-care measures. Complex and critical aspects of care, such as communication between providers, prevention of and response to complications, patient safety, and coordinated transitions to the outpatient environment, all contribute to patient outcomes but are difficult to measure by individual processes (Krumholz et al., 2007; Bradley et al., 2006). Clinical trials and observational studies suggest that several aspects of care provided to patients hospitalized for exacerbations of COPD can have significant effects on mortality, thus supporting the essential construct of mortality as an appropriate outcome to measure quality (Global Initiative for Chronic Obstructive Lung Disease [GOLD], 2009; National Collaborating Centre for Acute and Chronic Conditions, 2010; Walters et al., 2009; Lightowler et al., 2003). </p>
<p>The goal of outcomes measurement is to evaluate patient outcomes after accounting for patients' conditions at the time of hospital admission (hospital case-mix). This mortality measure was developed to identify hospitals whose performance is better or worse than would be expected based on their patient case-mix, and therefore promote hospital quality improvement and better inform consumers about care quality.</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>Bradley EH, Herrin J, Elbel B, McNamara RL, Magid DJ, Nallamothu BK, Wang Y, Normand SL, Spertus JA, Krumholz HM. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA. 2006 Jul 5;296(1):72-8. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16820549" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda (MD): Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2009. 93 p.  [447 references]</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Krumholz HM, Normand SL, Spertus JA, Shahian DM, Bradley EH. Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. Health Aff (Millwood). 2007 Jan-Feb;26(1):75-85. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17211016" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Lightowler JV, Wedzicha JA, Elliott MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003 Jan 25;326(7382):185. [16 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12543832" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>National Collaborating Centre for Acute and Chronic Conditions. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). London (UK): National Institute for Health and Clinical Excellence (NICE); 2010. &nbsp;(Clinical guideline; no. 101). </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Walters JA, Gibson PG, Wood-Baker R, Hannay M, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009;(1):CD001288.</td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research & Evaluation (CORE). Hospital-level 30-day mortality following admission for an acute exacerbation of chronic obstructive pulmonary disease: measure methodology report. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2011 Sep 29. 44 p.  [23 references]</td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Chronic obstructive pulmonary disease (COPD); respiratory failure; acute exacerbation of COPD; 30-day mortality rate</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The measure cohort consists of admissions for Medicare Fee-for-Service (FFS) beneficiaries aged 65 years or older discharged from non-federal acute care hospitals and critical access hospitals, having a principal discharge diagnosis of chronic obstructive pulmonary disease (COPD), as well as those with a principal discharge diagnosis of respiratory failure and secondary diagnosis of COPD with exacerbation.</p>
<p>The risk-standardized mortality rate (RSMR) is calculated as the ratio of the number of "predicted" deaths to the number of "expected" deaths at a given hospital, multiplied by the national observed mortality rate. For each hospital, the denominator is the number of deaths expected based on the nation's performance with that hospital's case mix.</p>
<p>See the related "Denominator Inclusions/Exclusions" field.</p>
<p class="Note"><strong>Note</strong>: This outcome measure does not have a traditional numerator and denominator like a core process measure; thus, this field is used to define the measure cohort.</p>
<p class="Note">See the <em>2017 Condition-specific Measures Updates and Specifications Report. Hospital-level 30-day Risk-standardized Mortality Measures</em> for more details.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The measure counts death from any cause within 30 days of the start of the index admission.</p>
<p>The risk-standardized mortality rate (RSMR) is calculated as the ratio of the number of "predicted" deaths to the number of "expected" deaths at a given hospital, multiplied by the national observed mortality rate. For each hospital, the numerator of the ratio is the number of deaths within 30 days predicted based on the hospital's performance with its observed case mix.</p>
<p class="Note"><strong>Note</strong>: This outcome measure does not have a traditional numerator and denominator like a core process measure; thus, this field is used to define the outcome.</p>
<p class="Note">See the <em>2017 Condition-specific Measures Updates and Specifications Report. Hospital-level 30-day Risk-standardized Mortality Measures</em> for more details.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
One or more research studies published in a National Library of Medicine (NLM) indexed, peer-reviewed journal
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Chronic obstructive pulmonary disease (COPD) is a priority condition for outcomes measure development because it is a leading cause of morbidity and mortality. COPD affects at least 15 and as many as 24 million individuals in the United States (U.S.), and is the nation's third leading cause of death (National Heart, Lung, and Blood Institute [NHLBI], 2009; Centers for Disease Control and Prevention [CDC], 2011; Wier et al., 2011; Xu et al., 2013; American Lung Association, 2016). Studies report that in-hospital mortality rates for patients hospitalized for exacerbations of COPD range from 2% to 5% (Agency for Healthcare Research and Quality [AHRQ], 2009; Patil et al., 2003; Tabak et al., 2009; Lindenauer et al., 2006; Dransfield et al., 2008) and 30-day mortality rates range from 3% to 9% (Faustini et al., 2008; Fruchter &amp; Yigla, 2008; Lindenauer et al., 2013). </p>
<p>In 2011, COPD was one of the top 20 most expensive conditions treated in U.S. hospitals (Torio &amp; Andrews, 2013). It was also one of the top 20 most expensive conditions billed to Medicare, accounting for nearly $4,074,000 of total hospital charges billed to Medicare (Torio &amp; Andrews, 2013). </p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<table><tr><td>Agency for Healthcare Research and Quality (AHRQ). Healthcare Cost and Utilization Project (HCUP) statistics on hospitals stays, 2009. [internet]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2009&nbsp;[accessed 2010 Sep 18]. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>American Lung Association. Lung health & diseases: how serious is COPD. [internet]. Chicago (IL): American Lung Association; 2016 Nov 1&nbsp;[accessed 2017 Oct 30]. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults--United States, 2011. MMWR Morb Mortal Wkly Rep. 2012 Nov 23;61(46):938-43. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23169314" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax. 2008 Apr;63(4):301-5. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17951276" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Faustini A, Marino C, D'Ippoliti D, Forastiere F, Belleudi V, Perucci CA. The impact on risk-factor analysis of different mortality outcomes in COPD patients. Eur Respir J. 2008 Sep;32(3):629-36. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18448492" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Fruchter O, Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology. 2008 Nov;13(6):851-5. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18811883" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Lindenauer PK, Grosso LM, Wang C, Wang Y, Krishnan JA, Lee TA, Au DH, Mularski RA, Bernheim SM, Drye EE. Development, validation, and results of a risk-standardized measure of hospital 30-day mortality for patients with exacerbation of chronic obstructive pulmonary disease. J Hosp Med. 2013 Aug;8(8):428-35. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23913593 " target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006 Jun 20;144(12):894-903. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16785478" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>National Heart, Lung, and Blood Institute (NHLBI). Morbidity & mortality: 2009 chart book on cardiovascular, lung, and blood diseases. Bethesda (MD): National Institutes of Health (NIH); 2009 Oct. 116 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Overview of hospitalizations among patients with COPD, 2008. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2011 Feb. 11 p. &nbsp;(HCUP statistical brief; no. 106). </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003 May 26;163(10):1180-6. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12767954" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009 Sep 28;169(17):1595-602. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19786679" target="_blank">PubMed</a></td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Aug. 12 p. &nbsp;(HCUP statistical brief; no. 160). </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep. 2016 Feb 16;64(2):1-119. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26905861 " target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Assessment of Updated Models</strong></p>
<p>The chronic obstructive pulmonary disease (COPD) mortality measure estimates hospital-specific 30-day all-cause risk-standardized mortality rates (RSMRs) using a hierarchical logistic regression model. Refer to Section 2 in the original measure documentation for a summary of the measure methodology and model risk-adjustment variables. Refer to prior methodology and technical reports for further details. </p>
<p>The Centers for Medicare &amp; Medicaid Services (CMS) evaluated and validated the performance of the models, using July 2013 to June 2016 data for the 2017 reporting period. They also evaluated the stability of the risk-adjustment model over the three-year measurement period by examining the model variable frequencies, model coefficients, and the performance of the risk-adjustment model in each yea. </p>
<p>CMS assessed logistic regression model performance in terms of discriminant ability for each year of data and for the three-year combined period. They computed two summary statistics to assess model performance: the predictive ability and the area under the receiver operating characteristic (ROC) curve (c-statistic). CMS also computed between-hospital variance for each year of data and for the three-year combined period. If there were no systematic differences between hospitals, the between-hospital variance would be zero. </p>
<p>The results of these analyses are presented in Section 4.3 of the original measure documentation. </p>
<p><strong>COPD Mortality 2017 Model Results</strong></p>
<p><em>Frequency of COPD Model Variables </em></p>
<p>CMS examined the change in the frequencies of clinical and demographic variables. Frequencies of model variables were stable over the measurement period. The largest changes in the frequencies (those greater than 2% absolute change) include increases in Asthma (16.3% to 23.8%), Cardio-respiratory failure and shock (35.3% to 40.1%), Other psychiatric disorders (30.4% to 33.1%), Other respiratory disorders (56.9% to 64.2%), and Renal failure (32.9% to 35.0%). </p>
<p><em>COPD Model Parameters and Performance </em></p>
<p>Table 4.3.2 in the original measure documentation shows hierarchical logistic regression model variable coefficients by individual year and for the combined three-year dataset. Table 4.3.3 in the original measure documentation shows the risk-adjusted odds ratios (ORs) and 95% confidence intervals for the COPD mortality model by individual year and for the combined three-year dataset. Overall, the variable effect sizes were relatively constant across years. In addition, model performance was stable over the three-year period; the c-statistic remained constant at 0.72.</p>
<p>Refer to the original measure documentation for additional information. </p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Extent of Measure Testing
</h3>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 condition-specific measures updates and specifications report: hospital-level 30-day risk-standardized mortality measures. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Mar. 98 p.  [29 references]</td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Hospital Inpatient
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Single Health Care Delivery or Public Health Organizations
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Specified
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age greater than or equal to 65 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Making Care Safer</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Getting Better
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Safety
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Discharges July 1, 2013 through June 30, 2016</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Clinical Condition
</div>
<div class='FieldValue'>
Institutionalization
</div>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
An <em>index admission</em> is the hospitalization to which the mortality outcome is attributed and includes admissions for patients: </p>
<ul style="list-style-type: disc;">
    <li>Principal discharge diagnosis of chronic obstructive pulmonary disease (COPD) or principal discharge diagnosis of respiratory failure with a secondary diagnosis of COPD with exacerbation* </li>
    <li>Enrolled in Medicare Fee-for-Service (FFS) Part A and Part B for the 12 months prior to the date of admission, and enrolled in Part A during the index admission </li>
    <li>Aged 65 or over </li>
    <li>Not transferred from another acute care facility </li>
</ul>
<p class="Note">*International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes used to define the COPD cohort for discharges on or after October 1, 2015:</p>
<ul class="Note" style="list-style-type: disc;">
    <li>J41.8 Mixed simple and mucopurulent chronic bronchitis </li>
    <li>J42 Unspecified chronic bronchitis </li>
    <li>J43.0 Unilateral pulmonary emphysema [MacLeod's syndrome] </li>
    <li>J43.1 Panlobular emphysema </li>
    <li>J43.2 Centrilobular emphysema </li>
    <li>J43.8 Other emphysema </li>
    <li>J43.9 Emphysema, unspecified </li>
    <li>J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection </li>
    <li>J44.1 Chronic obstructive pulmonary disease with (acute) exacerbation </li>
    <li>J44.9 Chronic obstructive pulmonary disease, unspecified </li>
</ul>
<p class="Note">Principal discharge diagnosis codes included in cohort if combined with a secondary diagnosis of J44.0 or J44.1:</p>
<ul class="Note" style="list-style-type: disc;">
    <li>J96.00 Acute respiratory failure, unspecified whether with hypoxia or hypercapnia </li>
    <li>J96.01 Acute respiratory failure with hypoxia </li>
    <li>J96.02 Acute respiratory failure with hypercapnia </li>
    <li>J96.20 Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia </li>
    <li>J96.21 Acute and chronic respiratory failure with hypoxia </li>
    <li>J96.22 Acute and chronic respiratory failure with hypercapnia </li>
    <li>J96.90 Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia </li>
    <li>J96.91 Respiratory failure, unspecified with hypoxia </li>
    <li>J96.92 Respiratory failure, unspecified with hypercapnia </li>
    <li>R09.2 Respiratory arrest </li>
</ul>
<p class="Note"><strong>Note</strong>: International Classification of Diseases, Ninth Revision (ICD-9) code lists for discharges prior to October 1, 2015 can be found in the <em><a href="http://www.qualitynet.org/dcs/ContentServer?cid=1228774398696&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;c=Page" title="QualityNet Web site">2016 Condition-specific Mortality Measures Updates and Specifications Report</a></em>.</p>
<p><strong>Exclusions</strong></p>
<ul style="list-style-type: disc;">
    <li>Inconsistent or unknown vital status or other unreliable demographic (age and gender) data </li>
    <li>Enrolled in the Medicare hospice program any time in the 12 months prior to the index admission, including the first day of the index admission </li>
    <li>Discharged against medical advice </li>
</ul>
<p>For patients with more than one eligible admission for COPD in a given year, only one index admission for that condition is randomly selected for inclusion in the cohort. Additional admissions within that year are excluded.</p></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
The measure counts death from any cause within 30 days of the start of the index admission.</p>
<p>The risk-standardized mortality rate (RSMR) is calculated as the ratio of the number of "predicted" deaths to the number of "expected" deaths at a given hospital, multiplied by the national observed mortality rate. For each hospital, the numerator of the ratio is the number of deaths within 30 days predicted based on the hospital's performance with its observed case mix.</p>
<p class="Note"><strong>Note</strong>: This outcome measure does not have a traditional numerator and denominator like a core process measure; thus, this field is used to define the outcome.</p>
<p class="Note">See the <em><a href="http://www.qualitynet.org/dcs/ContentServer?c=Page&amp;pagename=QnetPublic/Page/QnetTier3&amp;cid=1163010421830" title="QualityNet Web site">2017 Condition-specific Measures Updates and Specifications Report. Hospital-level 30-day Risk-standardized Mortality Measures</a></em> for more details.</p>
<p><strong>Exclusions</strong><br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Institutionalization
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Administrative clinical data
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Death
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a lower score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Description of Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Risk-Adjustment Variables</strong></p>
<p>In order to account for differences in case mix among hospitals, the measure adjusts for variables (for example, age, comorbid diseases, and indicators of patient frailty) that are clinically relevant and have relationships with the outcome. For each patient, risk-adjustment variables are obtained from inpatient, outpatient, and physician Medicare administrative claims data extending 12 months prior to, and including, the index admission.</p>
<p>The measure adjusts for case mix differences among hospitals based on the clinical status of the patient at the time of the index admission. Accordingly, only comorbidities that convey information about the patient at that time or in the 12 months prior, and not complications that arise during the course of the hospitalization, are included in the risk adjustment.</p>
<p>The measure does not adjust for socioeconomic status (SES) because the association between SES and health outcomes can be due, in part, to differences in the quality of healthcare that groups of patients with varying SES receive. The intent is for the measure to adjust for patient demographic and clinical characteristics while illuminating important quality differences. As part of the National Quality Forum's (NQF's) endorsement process for this measure, the Centers for Medicare &amp; Medicaid Services (CMS) completed analyses for the two-year Sociodemographic Trial Period. Although univariate analyses found that the patient-level observed (unadjusted) mortality rates are higher for dual-eligible patients (for patients living in lower Agency for Healthcare Research and Quality [AHRQ] SES Index census block groups) and African-American patients compared with all other patients, analyses in the context of a multivariable model demonstrated that the effect size of these variables was small, and that the c-statistics for the models are similar with and without the addition of these variables.</p>
<p>Refer to Appendix D of the original measure documentation for the list of comorbidity risk-adjustment variables and the list of complications that are excluded from risk adjustment if they occur only during the index admission. </p></div>
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Hospital-level 30-day RSMR following COPD.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
National Hospital Inpatient Quality Measures
</div>

</div>
<div class='field field_text'>
<h3>
Measure Set Name
</h3>
<div class='FieldValue'>
Mortality Measures
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
Centers for Medicare & Medicaid Services - Federal Government Agency [U.S.]
</div>
<div class='FieldValue'>
Yale-New Haven Health Services Corporation/Center for Outcomes Research and Evaluation under contract to Centers for Medicare & Medicaid Services - Academic Affiliated Research Institute
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Centers for Medicare &amp; Medicaid Services (CMS)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was developed by a team of clinical and statistical experts:</p>
<ul style="list-style-type: disc;">
    <li>David Au, MD, Department of Medicine, University of Washington </li>
    <li>Jerry Krishnan, MD, PhD, Departments of Medicine and Health Studies, University of Chicago </li>
    <li>Todd Lee, PharmD, PhD, Departments of Pharmacy Practice and Pharmacy Administration, University of Illinois at Chicago, Hines VA Hospital </li>
    <li>Richard Mularski, MD, MCR, MSHS, Oregon Health &amp; Science University </li>
    <li>Darlene Bainbridge, RN, MS, NHA, CPHQ, CPHRM, Darlene D. Bainbridge &amp; Associates, Inc. </li>
    <li>Robert A. Balk, MD, Rush University Medical Center </li>
    <li>Dale Bratzler, DO, MPH, Oklahoma Foundation for Medical Quality </li>
    <li>Scott Cerreta, RRT, COPD Foundation </li>
    <li>Gerard J. Criner, MD, Temple University </li>
    <li>Guy D'Andrea, MBA, Discern Consulting </li>
    <li>Jonathan Fine, MD, Norwalk Hospital </li>
    <li>David Hopkins, MS, PhD, Pacific Business Group on Health </li>
    <li>Fred Martin Jacobs, MD, JD, FACP, FCCP, FCLM, Saint Barnabas Quality Institute </li>
    <li>Natalie Napolitano, MPH, RRT-NPS, Inova Fairfax Hospital </li>
    <li>Russell Robbins, MD, MBA, Mercer </li>
    <li>Angela Merrill, MEcon, PhD, Mathematica Policy Research, Inc. </li>
    <li>Sandi Nelson, MPP, Mathematica Policy Research, Inc. </li>
    <li>Marian Wrobel, PhD, Mathematica Policy Research, Inc. </li>
    <li>Eric Schone, PhD, Mathematica Policy Research, Inc. </li>
    <li>Sharon-Lise T. Normand, PhD, Harvard School of Public Health </li>
    <li>Lein Han, PhD, CMS </li>
    <li>Joel Andress, PhD, CMS </li>
    <li>Michael Rapp, MD, CMS</li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>None</p></div>
</div>

</div>
<div class='field field_orglist'>
<h3>
Endorser
</h3>
<div class='FieldValue'>
National Quality Forum - None
</div>

</div>
<div class='field field_plain-text'>
<h3>
NQF Number
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Date of Endorsement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2017 Oct 3</p></div>
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Measure Initiative(s)
</h3>
<div class='FieldValue'>
Hospital Compare
</div>
<div class='FieldValue'>
Hospital Inpatient Quality Reporting Program
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure was not adapted from another source.</p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2017 Mar
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Annual</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>2018 Apr</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p>
<p>This measure updates a previous version: Specifications manual for national hospital inpatient quality measures, version 5.0b. Centers for Medicare &amp; Medicaid Services (CMS), The Joint Commission; Effective 2015 Oct 1. various p. </p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source available from the <a href="https://www.qualitynet.org/dcs/ContentServer?c=Page&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;cid=1163010421830" title="QualityNet Web site">QualityNet Web site</a>.</p>
<p>Check the QualityNet Web site regularly for the most recent version of the specifications manual and for the applicable dates of discharge.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Companion Documents
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Hospital compare: a quality tool provided by Medicare. [internet]. Washington (DC): U.S. Department of Health and Human Services; [accessed 2017 Oct 3]. This is available from the <a href="https://www.medicare.gov/hospitalcompare/search.html?" title="Medicare Web site" target="_blank">Medicare Web site</a>. </li>
    <li>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 Medicare hospital quality chartbook. Baltimore (MD): Centers for Medicare &amp; Medicaid Services (CMS); 2017. Available from the <a href="https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/OutcomeMeasures.html" title="Centers for Medicare &amp; Medicaid Services (CMS) Web site" target="_blank">Centers for Medicare &amp; Medicaid Services (CMS) Web site</a>. </li>
    <li>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 condition-specific mortality measures updates and specifications report: supplemental ICD-10 code lists for use with claims for discharges on or after October 1, 2015. Baltimore (MD): Centers for Medicare &amp; Medicaid Services (CMS); 2017. Available from the <a href="https://www.qualitynet.org/dcs/ContentServer?c=Page&amp;pagename=QnetPublic%2FPage%2FQnetTier4&amp;cid=1163010421830" title="QualityNet Web site">QualityNet Web site</a>. </li>
</ul></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on December 4, 2014. The information was verified by the measure developer on January 21, 2015.</p>
<p>This NQMC summary was updated by ECRI Institute on July 20, 2015. The information was verified by the measure developer on September 23, 2015.</p>
<p>This NQMC summary was updated again by ECRI Institute on October 17, 2017. The information was verified by the measure developer on November 9, 2017.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>No copyright restrictions apply.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Yale New Haven Health Services Corporation (YNHHSC), Center for Outcomes Research and Evaluation (CORE). 2017 condition-specific measures updates and specifications report: hospital-level 30-day risk-standardized mortality measures. Baltimore (MD): Centers for Medicare & Medicaid Services (CMS); 2017 Mar. 98 p.  [29 references]</td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>